---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-033248"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2023-04-27T23:59:59+00:00"
generated_at: "2026-06-16T09:09:42.944764+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nasdaq grants Bluejay Diagnostics extension to Oct 23, 2023 to regain $1 bid price

## Summary
- Company received original deficiency notice on Oct 25, 2022 for bid price below $1.
- Nasdaq extended compliance deadline to Oct 23, 2023; must close at $1+ for 10 consecutive days.
- Company may implement a reverse stock split, subject to stockholder approval, to regain compliance.
- If not compliant by deadline, Nasdaq will delist the stock; appeal rights available.
- No assurance of regaining or maintaining compliance with Nasdaq listing requirements.

## SEC filing metadata
- accession: 0001213900-23-033248
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2023-04-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390023033248/0001213900-23-033248-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390023033248/ea177565-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-033248
- JSON: https://secwatch.observer/filing/0001213900-23-033248.json
- Plain text: https://secwatch.observer/filing/0001213900-23-033248.txt

## Key facts
- Listing & Compliance Notices
  Bluejay Diagnostics, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: April 25, 2023, Nasdaq’s Listing Qualifications Staff notified the Company that it has extended the time period for the Company to regain compliance with the Minimum Bid Requirement until October 23, 2023. To regain compliance, the closing bid price of the Company’s common stock must be at least $1.00 or higher for a minimum of ten consecutive business days. The Company intends to continue to actively monitor the closing bid price of its common stock and will evaluate available options to regain compliance with the Minimum Bid Requirement. Specifically, the Company has confirmed to Nasdaq that
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390023033248/0001213900-23-033248-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.